{"entity":{"id":"nct07306624","kind":"trial","name":"Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer","aka":[],"tldr":"A phase 2 trial of Docetaxel in non-small-cell lung cancer and small-cell lung cancer, run by STCube, Inc., now recruiting.","summary":"Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer is a phase 2 interventional study registered as NCT07306624 by STCube, Inc., with 62 participants planned, started 2026-01-10 and due to reach its primary completion in 2027-08-31. Interventions recorded: Nelmastobart and Docetaxel. Conditions listed: Non Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07306624","url":"https://clinicaltrials.gov/study/NCT07306624"}],"tags":["ctgov-ingest"],"related":[],"cancers":["nsclc","sclc"],"sections":[],"technologies":[],"targets":[],"drugs":["docetaxel"],"companies":["stcube"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07306624","phase":"2","setting":"A Multicenter, Phase 2 Clinical Trial Based on an Adaptive Design to Evaluate the Safety and Efficacy of Nelmastobart in Combination With Docetaxel in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Who Are Resistant or Intolerant to Platinum-based Chemotherapy and/or Immunotherapy","sponsor":"STCube, Inc.","enrolled":62,"outcomes":[]},"route":"/trials/nct07306624/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"drug":[{"id":"docetaxel","kind":"drug","name":"Docetaxel","route":"/drugs/docetaxel/"}],"company":[{"id":"stcube","kind":"company","name":"STCube","route":"/companies/stcube/"}]}}